Efficacy and safety of calcitriol therapy for reduction of proteinuria in children with chronic kidney disease: an open-label randomized controlled trial
Jitendra Meena(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Ranjeet W. Thergaonkar(Command Hospital), Aditi Sinha, Arvind Bagga(All India Institute of Medical Sciences)
Cited by 2
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2009|176
Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome
|American Journal of Kidney Diseases|2003|140